N(1)-methylnicotinamide

Subscribe to Selected New Research on N(1)-methylnicotinamide

7 relevant articles (1 outcomes, 1 trials/studies) found for this Bio-Agent

Description: RN given refers to parent cpd

Also Known As:

1-methyl-3-carbamoylpyridinium; 1-methylnicotinamide; 3-(aminocarbonyl)-1-methylpyridinium; N(1)-methylnicotinamide bromide; N(1)-methylnicotinamide chloride; N(1)-methylnicotinamide cyanide; N(1)-methylnicotinamide fluoride; N(1)-methylnicotinamide iodide; N(1)-methylnicotinamide iodide, 3-(aminocarbonyl-13C)-labeled; N(1)-methylnicotinamide methylsulfate; N(1)-methylnicotinamide perchlorate; N(1)-methylnicotinamide tetrafluoroborate (1-)

Relationship Network

Bio-Agent Context: Research Results

Heterocyclic Compounds: 25

1-Ring Heterocyclic Compounds

Pyridines: 28

Nicotinic Acids: 11

Niacinamide: 975

N(1)-methylnicotinamide: 7

Heterocyclic Acids

Nicotinic Acids: 11

Niacinamide: 975

N(1)-methylnicotinamide: 7

Experts

1.	Biedron, Rafal: 1 article (01/2008)
2.	Bryniarski, Krzysztof: 1 article (01/2008)
3.	Chlopicki, Stefan: 1 article (01/2008)
4.	Jakubowski, Andrzej: 1 article (01/2008)
5.	Marcinkiewicz, Janusz: 1 article (01/2008)
6.	Kuykendall, Jim R: 1 article (12/2007)
7.	Cox, Ray: 1 article (12/2007)
8.	Kinder, David: 1 article (12/2007)
9.	Wieczorkowska, M: 1 article (11/2005)
10.	Gebicki, J: 1 article (11/2005)

Related Diseases

1.	Liver Cirrhosis (Hepatic Cirrhosis) 01/01/2000 - "To address this question, we evaluated the renal clearance of N(1)-methylnicotinamide (NMN), a marker of the renal secretory function, in healthy subjects and patients with liver cirrhosis of increasing severity, but with a normal glomerular filtration rate. " Order ALL the reference details at left...
2.	Rosacea (Acne Rosacea) 11/01/2005 - "Topical application of 1-methylnicotinamide in the treatment of rosacea: a pilot study." 11/01/2005 - "A metabolite of nicotinamide, 1-methylnicotinamide (MNA(+)), has anti-inflammatory properties, and this is the first study to test the effectiveness of this agent in treating rosacea. " Order ALL the reference details at left...
3.	Atherosclerosis (Atheroma) 01/01/2009 - "Activation of nicotinamide N-methyltrasferase and increased formation of 1-methylnicotinamide (MNA) in atherosclerosis." Order ALL the reference details at left...
4.	Parkinson Disease (Parkinson's Disease) 02/01/2002 - "Possible role of 1-methylnicotinamide in the pathogenesis of Parkinson's disease." Order ALL the reference details at left...
5.	Acute Erythroblastic Leukemia (Erythroleukemia) 12/01/2007 - "1-Methylnicotinamide stimulates cell growth and inhibits hemoglobin synthesis in differentiating murine erythroleukemia cells." Order ALL the reference details at left...

Related Drugs and Biologics

1.	Niacinamide (Nicotinamide)
2.	Tryptophan (L-Tryptophan)
3.	Streptozocin (Streptozotocin)
4.	Epoprostenol (Prostacyclin)
5.	Oxazolone
6.	Niacin (Nicotinic Acid)
7.	Hemoglobins (Hemoglobin)
8.	Coenzymes

Best Treatments:
Research Summary Report
on Liver Cirrhosis

CureHunter Patient-Physician Summary Reports collect in one document all the medications ever reported in the US National Library of Medicine—1949 to the present—to be effective against your target disease. CureHunter research summary reports will vary in length from 25 to 250 pages. Analytic charts allow you and your physicians to see at a glance your medication options—including new, promising, off-label and experimental all rated for clinical efficacy.

Free Updates for 1 Year
All 332 Outcomes
Top 200 Key Drugs and Biologics
Top 50 Key Therapies and Procedures
Detailed History Charts
Full Research Reference Details
Sample PDF Report on Psoriasis >>

Price:

$24.00 & Delivery via PDF download
updates for 1 year

Research Interface

Rapidly retrieve summaries of all the evidence for any disease in seconds. Save hours of search and analysis time. CureHunter is unlike any "search engine" you have ever used. Where standard "search engines" produce lists of links, CureHunter quantifies evidence, extracts it from the literature and calculates a result you can use to immediately facilitate evidence based decision making in Real Clinical Time.

Unlimited Disease, Drug and Therapy Search
2 clicks from Disease to Drug to Evidence
Trial References
All the Positive Outcomes
Detailed Relationship Timeline Charts
Full Article Reference Details
Includes Mobile Interface Subscription
One-click to FDA Products/Patents
Request Institution License Details >>

Price:

$490.00 access via web interface
1 year subscription

Proceed to Checkout >>

Mobile Interface

Retrieve summaries of all the evidence for any disease from your Mobile Phone or PDA. Accelerate decision making in the field. Speed up your study of new drug and disease domains. Refresh your knowledge on the road.

Access from any web enabled PDA or Phone
Trial references
All the Positive Outcomes
Drug and Therapy searches
Full Article Reference Details
Try Mobile Interface >>

Price:

$45.00 access via "curehunter.com/m"
1 year subscription

Proceed to Checkout >>